Motif Bio Ord 1p Market & Company News

14.06.2019 09:04 Motif Bio PLC Holding(s) in Company RNS
12.06.2019 17:52 Motif Bio PLC Holding(s) in Company RNS
06.06.2019 07:00 Motif Bio PLC Receipt of FDA Meeting Minutes RNS
31.05.2019 15:15 Motif Bio PLC Result of AGM RNS
31.05.2019 10:28 Motif Bio PLC Holding(s) in Company RNS
29.05.2019 11:36 Motif Bio PLC Holding(s) in Company RNS
22.05.2019 13:50 Motif Bio PLC AGM Statement RNS
22.05.2019 09:39 Motif Bio Plc Ord 1p Motif Bio forms research agreement with Otto-von-Guericke University Magdeburg SMW
22.05.2019 07:00 Motif Bio PLC Orphan Disease Opportunity for Iclaprim RNS
21.05.2019 07:00 Motif Bio PLC Iclaprim Data presented at ASM Microbe 2019 RNS
20.05.2019 18:14 Motif Bio PLC Holding(s) in Company RNS
03.05.2019 18:25 Motif Bio PLC Meeting with US FDA held as planned RNS
01.05.2019 08:31 Motif Bio Plc Ord 1p Motif Bio forms treatment cooperation pact with Lamellar Biomedical SMW
01.05.2019 07:00 Motif Bio PLC Motif Signs Agreement with Lamellar Biomedical RNS
26.04.2019 07:01 Motif Bio PLC Notice of AGM RNS
26.04.2019 07:00 Motif Bio PLC Appointment of Andrew Powell to Board of Directors RNS
16.04.2019 07:00 Motif Bio PLC Motif Presents New Iclaprim Data at ECCMID 2019 RNS
15.04.2019 09:30 Motif Bio Plc Ord 1p Motif Bio losses narrow as R&D expenses fall SMW
15.04.2019 07:00 Motif Bio PLC Fiscal Year 2018 Results RNS
04.04.2019 07:00 Motif Bio PLC Motif Bio to Present Iclaprim Data at ECCMID 2019 RNS
02.04.2019 17:43 Motif Bio PLC Holding(s) in Company RNS
01.04.2019 15:28 Motif Bio PLC Holding(s) in Company RNS
01.04.2019 14:17 Motif Bio PLC Holding(s) in Company RNS
26.03.2019 08:34 Motif Bio Plc Ord 1p Motif Bio raises £2.7m from share issue SMW
26.03.2019 07:00 Motif Bio PLC Motif Bio Raises RNS
25.03.2019 09:49 Motif Bio PLC Proposed Equity Fundraise RNS
20.03.2019 07:33 Motif Bio Plc Ord 1p Motif Bio to meet with FDA to discuss skin infection treatment approval SMW
20.03.2019 07:00 Motif Bio PLC Holding(s) in Company RNS
20.03.2019 07:00 Motif Bio PLC Motif Bio Granted Meeting with U.S. FDA RNS
18.03.2019 07:16 Motif Bio Plc Ord 1p Motif Bio chairman Richard Morgan stands down SMW
18.03.2019 07:00 Motif Bio PLC Appointment of Bruce Williams as Interim Chairman RNS
15.03.2019 07:01 Motif Bio PLC Holding(s) in Company RNS
07.03.2019 12:07 Motif Bio PLC Second Price Monitoring Extn RNS
07.03.2019 12:02 Motif Bio PLC Price Monitoring Extension RNS
19.02.2019 07:00 Motif Bio PLC Conference Call and Webcast RNS
18.02.2019 08:32 Motif Bio Plc Ord 1p Motif Bio to raise capital after making early debt repayment SMW
18.02.2019 07:00 Motif Bio PLC Amendment Agreement with Hercules Capital RNS
15.02.2019 16:28 Motif Bio PLC Holding(s) in Company RNS
15.02.2019 16:26 Motif Bio PLC Holding(s) in Company RNS
14.02.2019 07:00 Motif Bio PLC Complete Response Letter from the FDA RNS
05.02.2019 07:00 Motif Bio PLC Exercise of Warrants RNS
23.01.2019 16:31 Motif Bio PLC Exercise of Warrants RNS
01.11.2018 16:40 Motif Bio PLC Second Price Monitoring Extn RNS
01.11.2018 16:35 Motif Bio PLC Price Monitoring Extension RNS
31.10.2018 07:00 Motif Bio PLC Jefferies London Healthcare Conference RNS
30.10.2018 16:35 Motif Bio PLC Price Monitoring Extension RNS
16.10.2018 16:40 Motif Bio PLC Second Price Monitoring Extn RNS
16.10.2018 16:35 Motif Bio PLC Price Monitoring Extension RNS
03.10.2018 13:39 Motif Bio Plc Ord 1p Motif Bio presents wound treatment data at San Francisco conference SMW
03.10.2018 08:01 Motif Bio PLC Motif Bio Presents New Iclaprim Data at IDWeek RNS
Showing 1 to 50 of 344